Skip to main content
Clinical Trials/NCT01480999
NCT01480999
Completed
Not Applicable

A Prospective Study Evaluating Surgical and Quality of Life Outcomes in Robotics and Laparoscopy Compared to Laparotomy in Early Stage Endometrial Cancer

University Health Network, Toronto7 sites in 1 country550 target enrollmentNovember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer of the Endometrium
Sponsor
University Health Network, Toronto
Enrollment
550
Locations
7
Primary Endpoint
Surgical Outcomes
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The use of robotic surgery in the management of gynecologic cancers has increased exponentially in the United States since the implementation of technology in 2005. In Canada, access to the system is limited because of a lack of government funding. The government has been reluctant to fund this technology because robust data, on the true impact to patient care, is lacking.

This project will prospectively examine outcomes of women, with early stage endometrial cancer, treated surgically. Open surgery will be compared to minimally invasive surgery (MIS) which will include conventional laparoscopy and robotic surgery. The data collected will include detailed assessment of surgical data, peri-operative events, quality of life analysis, health economic evaluation and evaluation of MIS rates.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
August 2020
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Any type of histologically confirmed early stage (stage 1 or 2) cancer of the endometrium
  • ECOG Performance status of 0-1
  • Suitable candidate for surgery
  • Signed approved informed consent
  • Female, 18 years of age or older
  • Pre-operative health is graded as ASA I-III
  • Patients able to complete baseline questions either on their own or with assistance
  • Patient willing to comply with scheduled visits

Exclusion Criteria

  • Major abdominal surgery, chemotherapy or radiation within 3 months before the baseline visit
  • Evidence of diffuse peritoneal carcinomatosis by imaging or clinical exam
  • Unfit for surgery: concomitant disorders incompatible with the study or surgery (at the discretion of the investigator)
  • Patients who are breastfeeding or become pregnant during the study

Outcomes

Primary Outcomes

Surgical Outcomes

Time Frame: 6 months

Intraoperative complications as well as perioperative (time to discharge from hospital), early postoperative (\<4 weeks) and long-term morbidity (4 weeks to 6 months)

Quality of Life Outcomes

Time Frame: 6 months

Validated quality of life questionnaires to assess the time it takes a patient to return to normal activity or work, the effect of surgery on their day-to-day living, pain, body image, sexuality, social life as well as about the costs associated with their surgery.

Cost-effectiveness

Time Frame: 6 months

Compare cost-effectiveness between MIS (minimally invasive surgery) and open surgery for early stage endometrial cancer, by evaluating lengths of hospital stay, in hospital costs and out of hospital costs

Secondary Outcomes

  • Evolution of MIS rates(Prior to recruitment of the first patient and every 6 months for the duration of the study)

Study Sites (7)

Loading locations...

Similar Trials